Article Data

  • Views 338
  • Dowloads 149

Original Research

Open Access

Estrogen and progesterone expression of vessel walls with intravascular leiomyomatosis; Discussion of histogenesis

  • G. Kir1,*,
  • M. Kir2
  • A. Gurbuz3
  • A. Karateke3
  • F. Aker4

1Department of Pathology, Haydarpasa Numune Hospital, Istanbul, Turkey

2Department of Obstetrics and Gynecology, Acibadem Hospital, Haydarpasa Numune Hospital, Istanbul, Turkey

3Department of obstetrics and Gynecology, Zeynep Kami/ Maternity Hospital,Haydarpasa Numune Hospital, Istanbul, Turkey

4Department of Pathology, Haydarpasa Numune Hospital, Istanbul, Turkey

DOI: 10.12892/ejgo200403362 Vol.25,Issue 3,May 2004 pp.362-366

Published: 10 May 2004

*Corresponding Author(s): G. Kir E-mail:

Abstract

We report seven cases of intravenous leiomyomatosis. Growth beyond the uterus occurred in two of the seven cases in the broad ligament. One 21-year-old patient is one of the youngest reported cases in the literature. Five patients had total abdominal hysterectomy with removal of the adnexa and two patients underwent myomectomy. One of the myomectomy cases had abdominal hysterectomy and bilateral salpingo-oophorectomy one year later due to recurrence. The other one was disease free six months after the operation. Vessel walls harboring intravascular tumor were investigated immunohistochemically for Factor VIII, CD 34, estrogen and progesterone receptors with the hope of making the histogenesis of intravenous leiomyomatosis clear. Immunohistochemical analyses of estrogen receptors, progesterone receptors, vimentin, desmin, smooth muscle actin, CD 10 and h-caldesmon were performed on intravascular tumor cells. Endothelial and subendothelial cells expressed none to scant, very weak progesterone and estrogen receptor positivity. Intravascular tumor cells showed weak (10%) to strong (70%) progesterone receptor positivity and weak (10%) to strong (60%) estrogen receptor positivity. These results do not support the hypothesis of a vessel wall origin for intravenous leiomyomatosis.

Keywords

Intravenous leiomyomatosis; Uterus

Cite and Share

G. Kir,M. Kir,A. Gurbuz,A. Karateke,F. Aker. Estrogen and progesterone expression of vessel walls with intravascular leiomyomatosis; Discussion of histogenesis. European Journal of Gynaecological Oncology. 2004. 25(3);362-366.

References

[1] Norris H.J.. Parmley T., Maj M.C.: "Mesenchymal tumors of the uterus. V. Intravenous leiomyomatosis. A clinical and pathologic study of 14 cases". Cancer, 1975, 36, 2164.

[2] Clement P.B.: "Intravenous leiomyomatosis of the uterus". Pathol Annual., 1988, 23, 153.

[3] Mulvany N.J., Slavin D.W., Ostor A.G., Fortune D.W.: "Intravenous leiomyomatosis of the uterus: a clinicopathologic study of 22 cases". Int. J. Gynecol. Pathol., 1994, 13, 1.

[4] Nogales F.F., Navarro N., Victoria J.M.M., Conteras F., Redondo C., Herraiz M.A. et al.: "Uterine intravascular leiomyomatosis: an update and report of seven cases". Int. J. Gynacol. Pathol., 1987, 6, 331.

[5] Heinonen P.K.,T aina T.N.,Ta ulaniemi E.,A me R.O.,K auppila 0.: "Intravenous leiomyomatosis". Ann. Chir. Gynaecol., 1984, 73, 100.

[6] Gehr N.R., Lund 0., Alstrup P., Nielsen J.S., Villadsen A.B., Bartholdy N.: "Recurence of uterine intravenous leiomyomatosis with intracardiac extension. Diagnostic considerations and surgical removal". Scand. Cardiovasc. J., 1999, 33,312.

[7] Nakayama Y., Kitamura S., Kawachi K., Kawata T., F ukutomi M., Hasegawa J., Morita R.: "Intravenous leiomyomatosis extending into the right atrium". Cardiovasc. Surg., 1994, 2, 642.

[8] Suginami H., Kaura R., Ochi H., Matsuura S.: "Intravenous leiomyomatosis with cardiac extension: successful surgical management and histopathologic study". Obstet. Gynecol., 1990, 76, 527.

[9] Okamoto H., Itoh T., Morita S., Matsuura A., Yasuura K.: "Intravenous leiomyomatosis extending into the right ventricle onestage radical excision during hypothermic circulatory arrest" Thorac. Cardivasc. Surg., 1994, 42, 361.

[10] Tierney W.M., Ehrlich C.E., Bailey J.C., King R.D., Roth L.M., Wann S.: "Intravenous leiomyomatosis of the uterus with extension into the heart". Am. J. Med., 1980, 69, 471.

[11] Diakomanolis E., Elsheikh A., Sotiropoulou M., Voulgaris Z., V lachos G., Loutradis D., Michales S.: "Intravenous leiomyomatosis". Arch. Gynecol. Obstet., 2003, 267, 256.

[12] Lam P.M., Lo W.K., Yu M.Y., Lau T.K., Cheung T.H.: "Intravenous leiomyomatosis with atypical histologic features: a case report". Int. J. Gynecol. Cancer, 2003, 13, 83.

[13] Clement P.B.,Y oung R.H., Scully R.E.: "Intravenous leiomyomatosis of the uterus a clinicopathological analysis of 16 cases with unusual histologic features". Am. J. Surg. Pathol., I 988, 12, 932.

[14] Andrade L.A., Torresan R.Z., Sales J.F., Vicentini R., De Souza G.A.: "Intravenous leiomyomatosis of the uterus. A report of three cases". Pathol. Oncol. Res., 1998, 4, 44.

[15] Bahary C.M., Gorodeski LG., Nilly M. et al.: "Intravascular leiomyomatosis". Obstet. Gynecol., 1982, (suppl.) 59, 73.

[16] Oliva E.,Y oung R.H.,A min M.B.,C lement P.B.: "An immunoh1stochemical analysis of endometrial stromal and smooth muscle tumors of the uterus. A study of 54 cases emphasizing the importance of using a panel because of overlap in immonoreactivi ty for individual antibodies". Am. J. Surg. Pathol., 2002, 26, 403.

[17] Chu P., Arber D.A.: "Paraffin-section detection of CD IO in 505 nonhematopoietic neoplasms. F requent expression in renal cell carcinoma and endometrial stromal sarcoma". Am. J. Clin. Pathol., 2000, I13, 374.

[18] Chu P.G., Arber D.A., Weiss L.M., Karen L.C.: "Utility of CD 10 in distinguishing between endometrial stromal sarcoma and uterine smooth muscle tumors: an immunohistochemical comparison of 34 cases". Mod. Pathol., 2001, 14, 465.

[19] Nucci M.R., O'Connel J.T., Huettner P.C., Cviko A., Sun D., Quade B.J.: "h-caldesmon expression effectively distinguishes endometrial stromal tumors from smooth muscle tumors". Am. J. Surg. Pathol., 200 I, 25, 455.

[20] Matsumoto K., Yamamoto T., Hisayoshi T.,Asano G.: "Intravenous leiomyomatosis of the uterus with multiple pulmonary metastases associated with large bullae-like cyst formation". Pathol. Int., 2001, 51, 396.

[21] W ray R.D., Dawkins H.: "Primary smooth muscle tumors of the inferior vena cava". Am. J. Surg., 1971, 174, 1009.

[22] Irey N.S., Norris H.J., Washington D.C.: "Intimal vascular lesions associated with female reproductive steroids". Arch. Pathol., 1973, 96, 227.

[23] Herr J.C., Platz C.E., Heidger P.M., Curet L.B.: "Smooth muscle within ovarian decidual nodules: a link to leiomyomatosis peritonealis disseminata?". Obstet. Gynecol., 1979, 53, 451.

[24] Mitsuhashi A., Nagai Y., Sugita M., Nakajima N., Sekiya S.: "GnRH agonist for intravenous leiomyomatosis with cardiac extension. A case report". J. Reprod. Med., 1999, 44, 883.

[25] Kokawa K., Yamoto M., Yata C., Mabuchi Y., Umesaki N.: "Postmenopousal intravenous leiomyomatosis with high levels estradiol and estrogen receptor". Obstet. Gynecol., 2002, 100, 1124.

[26] Orimo A., Inoue S., Ikegami A. et al.: "Vascular smooth muscle cells as target for estrogen". Biochem. Biophy. Res. Com., 1993, 195, 730.

[27] Karas R.H., baur W.E.,Eickles V.M., Mendelson M.E.: "Human vascular smooth muscle cells an estrogen receptor isoform". FEBS Lett., 1995, 18, 103.

[28] Hodges Y.K., Richer J.K., Horvitz K.B., Horvitz L.D.: "Variant estrogen and progesterone receptor messages in human vascular smooth muscle". Circulation, 1999, 25, 2688.

[29] Momeo B., T scheuschilsuren G., Aust G., Metz S., SpanelBorowski K.: "Estrogen receptor expression and synthesis in the human internal thorasic artery". Ann. Anal., 2003, 185, 57.

Abstracted / indexed in

Science Citation Index Expanded (SciSearch) Created as SCI in 1964, Science Citation Index Expanded now indexes over 9,500 of the world’s most impactful journals across 178 scientific disciplines. More than 53 million records and 1.18 billion cited references date back from 1900 to present.

Biological Abstracts Easily discover critical journal coverage of the life sciences with Biological Abstracts, produced by the Web of Science Group, with topics ranging from botany to microbiology to pharmacology. Including BIOSIS indexing and MeSH terms, specialized indexing in Biological Abstracts helps you to discover more accurate, context-sensitive results.

Google Scholar Google Scholar is a freely accessible web search engine that indexes the full text or metadata of scholarly literature across an array of publishing formats and disciplines.

JournalSeek Genamics JournalSeek is the largest completely categorized database of freely available journal information available on the internet. The database presently contains 39226 titles. Journal information includes the description (aims and scope), journal abbreviation, journal homepage link, subject category and ISSN.

Current Contents - Clinical Medicine Current Contents - Clinical Medicine provides easy access to complete tables of contents, abstracts, bibliographic information and all other significant items in recently published issues from over 1,000 leading journals in clinical medicine.

BIOSIS Previews BIOSIS Previews is an English-language, bibliographic database service, with abstracts and citation indexing. It is part of Clarivate Analytics Web of Science suite. BIOSIS Previews indexes data from 1926 to the present.

Journal Citation Reports/Science Edition Journal Citation Reports/Science Edition aims to evaluate a journal’s value from multiple perspectives including the journal impact factor, descriptive data about a journal’s open access content as well as contributing authors, and provide readers a transparent and publisher-neutral data & statistics information about the journal.

Submission Turnaround Time

Conferences

Top